No Data
No Data
Craig-Hallum Maintains Lineage Cell Therapeutics(LCTX.US) With Buy Rating
Craig-Hallum Initiates Lineage Cell Therapeutics(LCTX.US) With Buy Rating
Earnings Preview: LCTX to Report Financial Results Post-market on November 14
Press Release: Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
Express News | Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024
Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit
No Data
No Data